Tirzepatide
Appetite regulation and weight management support
Estimated amount due today at checkout
$249
1-month supply · one-time payment
What happens next
A calm, online process
Treatment availability depends on eligibility and clinician review. Nothing on this page guarantees prescribing, approval, or specific outcomes.
Complete your intake
A short intake captures the context your clinician needs to review your file.
Clinician chart review
A licensed clinician reviews your information and approves, requests more, or declines treatment.
Discreet fulfillment
When prescribed, fulfillment is handled through the partnered pharmacy with discreet packaging.
About Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that may be considered in clinician-supervised weight-management programs.
Treatment is determined by a licensed clinician after review. Not all patients are candidates. Individual results vary.
Who should not use this
Tirzepatide is not appropriate for everyone. It is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN2, for people with type 1 diabetes, or during pregnancy. Your intake also asks about pancreatitis, gallbladder disease, gastroparesis, eating disorders, diabetes and how it is treated, and any procedure requiring anesthesia in the next eight weeks.
Important safety information
This page is informational and does not replace medical advice from a licensed professional. Treatment availability depends on eligibility, clinician review, and applicable requirements. ElliotMeds does not provide emergency medical services — if you are experiencing a medical emergency, call 911 or go to the nearest emergency room.
See our other treatments
Explore other clinician-reviewed treatment programs.
